NCT06503926

Completed

Impact of COVID-19 Vaccination on Balance Function Among Ado...

Sinai University Source

Compare

Other study identifiers

Sponsor study identifier

P.T.REC/012/005002

Study Type

observational

Actual enrollment (reported)

270

Locations

1 country

Sites

1

Timeline

Study Start

December 6, 2023

Actual (reported)

Primary Completion

April 30, 2024

Actual (reported)

Study Completion

July 1, 2024

Actual (reported)

Brief Summary

Long term impact of COVID 19 vaccination on dizziness-related disability and balance in adolescence

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 270 participants
Study completion date: July 1, 2024
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
August 11, 2023
Actual (reported)
Study Start
December 6, 2023
Actual (reported)
Primary Completion
April 30, 2024
Actual (reported)
Study Completion
July 1, 2024
Actual (reported)
First Posted
July 16, 2024
Actual (reported)

Last Updated: July 16, 2025
Status Verified: July 2025
Last Update Submitted: July 12, 2025

Conditions

SARS CoV 2 Vaccination

Outcome Measures

Primary Outcomes (2)

Impact on Balance
The pediatric balance scale is used to assess balance (Lowest score =0 " worst"- Maximum score is 56 " Perfect Balance"
Through study completion, an average of 1 day - 1 year after taking the vaccine
Functional Disability
The Dizziness Handicap Inventory is used to assess functional disability related to dizziness
Through study completion, an average of 1 day - 1 year after taking the vaccine

Secondary Outcomes (2)

Emotional Disability
Through study completion, an average of 1 day - 1 year after taking the vaccine
Physical Disability
Through study completion, an average of 1 day - 1 year after taking the vaccine

Interventions

SARS-COV-2 vaccinationOther

Vaccination

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age10 Years - 17 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17)

Sampling MethodProbability Sample

Study Population

* Adolescence age range 10-17 * Vaccinated by any available SARS -COV-2 Vaccinations

You may qualify if:

Adolescence age range 10-17

Sponsors & Collaborators

Sinai University
Otherlead

Study Sites (1)

Sinai University

Ismailia, Ismailia Governorate, 11749, Egypt

Enrollment

270 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Lecturer

Study Record Dates

First Submitted

August 11, 2023

First Posted

July 16, 2024

Study Start

December 6, 2023

Actual (reported)

received a dose or more of an approved COVID-19 vaccine at least one year before the study enrollment.

the ability to complete all assessment measures independently.

You may not qualify if:

vestibular or neurological disorders diagnosed before vaccination.
mixed COVID-19 vaccine types.
a history of traumatic brain injury.
current use of medications that affect balance.
documented COVID-19 infection within three months of assessment.
physical limitations that prevented them from completing balance testing.

Contact the study team to confirm eligibility.

Primary Completion

April 30, 2024

Actual (reported)

Study Completion

July 1, 2024

Actual (reported)

Last Updated

July 16, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT06503926
Data provider: ClinicalTrials.gov
Source updated: 2025-07-16
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:46 UTC

Locations

EG(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

Primary Completion

Study Completion

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations